StockData
Edesa Biotech, Inc. logo

Edesa Biotech, Inc. (EDSA) stock

EDSANasdaqPharmaceutical PreparationsFiscal year ends September 30
Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 13, 2026Score 5/30
$2.00−0.17 (-8.05%)

Close on Nov 20, 2026Market cap $19.28MP/E –Yield –

Edesa Biotech free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

Edesa Biotech's free cash flow for the twelve months ending Sep 30, 2023 was -$6.64M. For fiscal 2023 it was -$6.64M. The highest annual figure on record is -$2.81M in fiscal 2013.

Annual free cash flow

PeriodPeriod endValueChange
FY2023Sep 30, 2023-$6.64M–
FY2022Sep 30, 2022-$12.28M–
FY2021Sep 30, 2021-$13.67M–
FY2020Sep 30, 2020-$4.99M–
FY2018Sep 30, 2018-$5.00M–
FY2017Sep 30, 2017-$5.00M–
FY2016Sep 30, 2016-$4.91M–
FY2014Aug 31, 2014-$4.55M–
FY2013Aug 31, 2013-$2.81M–
FY2012Aug 31, 2012-$4.03M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2023CQ3 2023Sep 30, 2023-$1.47M–
Q3 FY2023CQ2 2023Jun 30, 2023-$1.81M–
Q2 FY2023CQ1 2023Mar 31, 2023-$1.57M–
Q1 FY2023CQ4 2022Dec 31, 2022-$1.79M–
Q4 FY2022CQ3 2022Sep 30, 2022-$5.63M–
Q3 FY2022CQ2 2022Jun 30, 2022-$3.03M–
Q2 FY2022CQ1 2022Mar 31, 2022-$417.85K–
Q1 FY2022CQ4 2021Dec 31, 2021-$3.21M–
Q4 FY2021CQ3 2021Sep 30, 2021-$353.86K–
Q3 FY2021CQ2 2021Jun 30, 2021-$3.12M–
Q2 FY2021CQ1 2021Mar 31, 2021-$7.18M–
Q1 FY2021CQ4 2020Dec 31, 2020-$3.01M–
Q4 FY2020CQ3 2020Sep 30, 2020-$1.68M–
Q3 FY2020CQ2 2020Jun 30, 2020-$1.35M–
Q2 FY2020CQ1 2020Mar 31, 2020-$1.17M–
Q1 FY2020CQ4 2019Dec 31, 2019-$789.71K–
Q3 FY2019CQ2 2019Jun 30, 2019-$3.12M–
Q2 FY2019CQ1 2019Mar 31, 2019-$394.72K–
Q1 FY2019CQ4 2018Dec 31, 2018-$388.01K–
Q4 FY2018CQ3 2018Sep 30, 2018-$992.64K–
Q3 FY2018CQ2 2018Jun 30, 2018-$1.27M–
Q2 FY2018CQ1 2018Mar 31, 2018-$1.56M–
Q1 FY2018CQ4 2017Dec 31, 2017-$1.18M–
Q4 FY2017CQ3 2017Sep 30, 2017-$1.22M–
Q3 FY2017CQ2 2017Jun 30, 2017-$1.01M–
Q2 FY2017CQ1 2017Mar 31, 2017-$1.32M–
Q1 FY2017CQ4 2016Dec 31, 2016-$1.45M–
Q4 FY2016CQ3 2016Sep 30, 2016-$1.30M–

More Edesa Biotech figures

See a number that looks wrong?